Belite Bio (BLTE) Depreciation and Depletion (2024 - 2025)

Belite Bio's (BLTE) quarterly Depreciation and Depletion came in at $45000.0 in Q4 2025, up 4.65% year-on-year from $43000.0 in Q4 2024, and up 4.65% quarter-over-quarter from $43000.0 in Q4 2024.

Belite Bio (BLTE) Depreciation and Depletion (2024 - 2025) Analysis & Trends

Belite Bio's Depreciation and Depletion history runs 2 years deep, the most recent figure standing at $45000.0 for Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 196,658.72
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 39.39 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.20 Mn
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 45,000.00
Dec 31, 2025 45,000.00
Dec 31, 2024 43,000.00
Dec 31, 2024 43,000.00